met Apotheken
0782.370.920 · rovalta.com · 24/09/2026
met Apotheken
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOmet Apotheken is a Private limited company incorporated in 2022. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bree. It employs on average 2,6 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0782.370.920
- Incorporation
- 18/02/2022
- Legal form
- Private limited company
- Registered office
- Witte Torenwal 41
3960 Bree · FlandreSee on map - Contributed capital
- 75 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,6 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 434,7 k € | -3.6% | 451 k € | -10.7% | 504,9 k € | +92.6% | 262,1 k € |
| EBITDA | 246,5 k € | -28.6% | 345 k € | -16.9% | 415,3 k € | +58.5% | 262,1 k € |
| Operating result | 238,5 k € | -29.9% | 340,2 k € | -17.4% | 411,7 k € | +58.1% | 260,4 k € |
| Net result | 399,1 k € | +6.5% | 374,6 k € | +35.9% | 275,6 k € | +67.4% | 164,6 k € |
| Balance sheet | |||||||
| Equity | 1,3 M € | +44.7% | 888,7 k € | +72.5% | 515,2 k € | +115% | 239,6 k € |
| Total assets | 8 M € | +41.4% | 5,7 M € | +3.0% | 5,5 M € | +3.8% | 5,3 M € |
| Cash | 153,8 k € | +339% | 35,1 k € | -56.4% | 80,5 k € | -44.4% | 144,9 k € |
| Debts | 6,8 M € | +40.7% | 4,8 M € | -4.2% | 5 M € | -1.5% | 5,1 M € |
| Other | |||||||
| Workforce | 2,6 ETP | +62.5% | 1,6 ETP | +33.3% | 1,2 ETP | – | |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20254 active
Active mandates
Other companies at this address
Witte Torenwal 41 3960 Bree| Company | CBE no. |
|---|---|
Apotheek VAN DIJCK● Active | 0821.385.508 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 18/02/2022 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 11 months |
| Filing date | 22/07/2026 | 09/07/2025 | 22/08/2024 | 25/08/2023 |
| General meeting | 25/06/2026 | 26/06/2025 | 27/06/2024 | 29/06/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20254 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025399,1 k €↑
- 2024Annual accounts 2024374,6 k €↑
- 2023Annual accounts 2023275,6 k €↑
- 2022Annual accounts 2022164,6 k €
- 18/02/2022IncorporationPrivate limited company